Sleep Medicines Approved in the EU (EMA)

Medicines the European Medicines Agency has recommended for use in the European Union on this topic.

Each number has its full source under its own list below.

Medicines authorised in the EU

9 medicines (authorised now). Newest first. Each links to its EMA page.

At the source
  • Melatonin Neurim

    Active substance: melatonin

    EMEA/H/C/005603
  • Quviviq

    Active substance: daridorexant hydrochloride

    EMEA/H/C/005634
  • Wegovy

    Active substance: semaglutide

    EMEA/H/C/005422
  • Ozawade

    Active substance: pitolisant

    EMEA/H/C/005117
  • Sunosi

    Active substance: solriamfetol hydrochloride

    EMEA/H/C/004893
  • Slenyto

    Active substance: melatonin

    EMEA/H/C/004425
  • Hetlioz

    Active substance: tasimelteon

    EMEA/H/C/003870
  • Saxenda

    Active substance: liraglutide

    EMEA/H/C/003780
  • Circadin

    Active substance: melatonin

    EMEA/H/C/000695

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

Acuitas market sizes and forecasts are only in our full reports. How we use public data.